Fernandez-Luna J L, Mendez E, Leyva-Cobian F
Servicio de Endocrinologia, Centro Ramon y Cajal, Madrid, Spain.
Am J Clin Pathol. 1989 Jan;91(1):88-91. doi: 10.1093/ajcp/91.1.88.
Protein HC is a low molecular weight glycoprotein that is present as free form and in complex with IgA (HC-IgA) in human body fluids. In the present report, a combined competitive and sandwich enzyme-linked immunsorbent assay (ELISA) was used to measure the levels of protein HC and its IgA complex independently in the sera of patients with malignant melanoma. The concentration of these proteins correlated with IgA levels and clinical staging. The main findings can be summarized as follows: (1) protein HC and protein HC-IgA complex levels presented the most significant elevation in melanoma stages IVA and IVB; (2) a significant positive correlation was found between protein HC and protein HC-IgA complex values and the clinical stage of the tumor; (3) protein HC-IgA complex and IgA concentrations are parameters with positive correlation both in normal controls and in patients with melanoma; (4) in normal sera, the levels of protein HC and protein HC-IgA complex are not correlated, however, they are negatively correlated in melanoma.
蛋白HC是一种低分子量糖蛋白,以游离形式和与IgA结合的复合物(HC-IgA)形式存在于人体体液中。在本报告中,采用竞争和夹心酶联免疫吸附测定(ELISA)相结合的方法,独立测定恶性黑色素瘤患者血清中蛋白HC及其IgA复合物的水平。这些蛋白质的浓度与IgA水平和临床分期相关。主要研究结果总结如下:(1)在黑色素瘤IVA期和IVB期,蛋白HC和蛋白HC-IgA复合物水平升高最为显著;(2)蛋白HC和蛋白HC-IgA复合物值与肿瘤临床分期之间存在显著正相关;(3)在正常对照和黑色素瘤患者中,蛋白HC-IgA复合物和IgA浓度均呈正相关;(4)在正常血清中,蛋白HC和蛋白HC-IgA复合物水平不相关,但在黑色素瘤患者中呈负相关。